Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Buy
110,673
+16,643
+18% +$27.1K ﹤0.01% 6793
2026
Q1
$166K Buy
94,030
+85,962
+1,065% +$483K ﹤0.01% 6734
2025
Q4
$52.5K Sell
8,068
-234,383
-97% -$1.22M ﹤0.01% 7194
2025
Q3
$1.12M Buy
242,451
+229,089
+1,714% +$369K ﹤0.01% 5471
2025
Q2
$14.8K Sell
13,362
-20,907
-61% -$29.6K ﹤0.01% 8636
2025
Q1
$48.1K Buy
34,269
+22,253
+185% +$45.8K ﹤0.01% 7631
2024
Q4
$45.5K Buy
12,016
+4,222
+54% +$26.3K ﹤0.01% 7360
2024
Q3
$66.6K Buy
7,794
+2,998
+63% +$35.5K ﹤0.01% 6634
2024
Q2
$76.5K Sell
4,796
-5,261
-52% -$75.4K ﹤0.01% 6360
2024
Q1
$148K Sell
10,057
-857
-8% -$10.1K ﹤0.01% 6038
2023
Q4
$74.2K Buy
10,914
+5,764
+112% +$31.6K ﹤0.01% 6351
2023
Q3
$26.2K Sell
5,150
-335
-6% -$2.14K ﹤0.01% 6663
2023
Q2
$49K Buy
5,485
+32
+0.6% +$418 ﹤0.01% 6489
2023
Q1
$66.7K Buy
5,453
+1,407
+35% +$22K ﹤0.01% 6226
2022
Q4
$54.1K Buy
4,046
+282
+7% +$3.64K ﹤0.01% 6695
2022
Q3
$34K Buy
3,764
+3,287
+689% +$32.3K ﹤0.01% 6736
2022
Q2
$5K Buy
+477
New +$5.32K ﹤0.01% 8917

Other funds holding PEPG

UBS Group's PEPG Position: Q2 2026 in Review

UBS Group increased its PepGen (PEPG) stake by 18% in Q2 2026, buying an estimated $27.1K and bringing the position to 110,673 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #6793.

UBS Group first reported a position in PEPG in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.12M in Q3 2025. 72 funds tracked by Wall St. Rank hold PEPG as of Q2 2026.

  • UBS Group held 110,673 shares of PepGen worth $199K as of Q2 2026.
  • UBS Group bought 16,643 PepGen shares in Q2 2026, an estimated $27.1K.
  • PepGen made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6793 holding.
  • UBS Group first reported a position in PepGen in Q2 2022 and has held it in 17 quarters since.
  • UBS Group's PepGen position peaked at $1.12M in Q3 2025.
  • 72 funds tracked by Wall St. Rank held PepGen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.